Intravascular device administration sets: Replacement after standard versus prolonged use in hospitalised patients - A study protocol for a randomised controlled trial (The RSVP Trial)

BMJ Open

Volumn 5, Issue 2, 2015, Pages

  Rickard, Claire M ^a,b,c,d   Marsh, Nicole M ^a,b   Webster, Joan ^a,b   Gavin, Nicole C ^a,b   McGrail, Matthew R ^e   Larsen, Emily ^a,b   Corley, Amanda ^a,d   Long, Debbie ^a,f   Gowardman, John R ^a,b   Murgo, Marghie ^g,h   Fraser, John F ^a,d   Chan, Raymond J ^a,b,i   Wallis, Marianne C ^a,j   Young, Jeanine ^f,j   McMillan, David ^j   Zhang, Li ^a   Choudhury, Md Abu ^a,b   Graves, Nicholas ⁱ   Geoffrey Playford, E ^a,c  

^a GRIFFITH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF BALLARAT   (Australia)

^f LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^g Clinical Excellence Commission   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^j UNIVERSITY OF THE SUNSHINE COAST   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY CATHETER; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER CARE; CATHETER REMOVAL; CATHETER REPLACEMENT; CENTRAL VENOUS CATHETER; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; FUNGEMIA; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MEDICAL ETHICS; MICROBIAL COLONIZATION; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT RISK; PATIENT SAFETY; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PROGRAM FEASIBILITY; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICE REMOVAL; HOSPITALIZATION; INDWELLING CATHETER; KAPLAN MEIER METHOD; METHODOLOGY; MULTICENTER STUDY; PHLEBITIS; STANDARDS; VASCULAR ACCESS DEVICE;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CLINICAL PROTOCOLS; DEVICE REMOVAL; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; PHLEBITIS; RESEARCH DESIGN; VASCULAR ACCESS DEVICES;

EID: 84922349623     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007257     Document Type: Article

References (38)

1. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachmann PS. eds. Hospital infections. 3rd edn. Boston: Little Brown and Co. Inc, 1992:849-98.
2. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-71.
3. Maki DG, Rhame FS, Mackel DC, et al. Nationwide epidemic of septicaemia caused by contaminated intravenous products: I. Epidemiologic and clinical features. Am J Med 1976;60:471-85.
4. Millam D. The history of intravenous therapy. J Intraven Nurs 1996;19:5-14.
5. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979;91:173-8.
6. Eggimann P, Pittett D. Catheter-related infections in the ICU. In: Vincent JL., ed. Yearbook of intensive care and emergency medicine. Springer, 2000:95-110.
7. Josephson A, Gombert ME, Sierra MF, et al. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367-70.
8. Rickard CM, Lipman J, Courtney M, et al. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters. Infect Control Hosp Epidemiol 2004;25:650-5.
9. Ullman AJ, Cooke ML, Gillies D, et al. Optimal timing for intravascular administration set replacement. Cochrane Database Syst Rev 2013;9:CD003588.
10. Fox M, Molesky M, Van Aerde JE, et al. Changing parenteral nutrition administration sets every 24 h versus every 48 h in newborn infants. Can J Gastroenterol 1999;13:147-51.
11. Matlow AG, Kitai I, Kirpalani H, et al. A randomised controlled trial of 72-versus 24-hour intravenous tubing administration set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol 1999;20:487-93.
12. Raad I, Hanna HA, Awad A, et al. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol 2001;22:136-9.
13. Blight I, Amadio J, Thomas P, et al. Randomised prospective study of replacing intravenous administration sets at 72 hours versus 120 hour intervals in central venous catheters. Conference proceedings of the 4th Nursing Practice Conference. 1998: Adelaide, Australia.
14. Jakobsen CJ, Grabe N, Nielsen E, et al. Contamination of intravascular infusion systems-the effect of changing administration sets. J Hosp Infect 1986;8:217-23.
15. Luskin RL, Weinstein RA, Nathan C, et al. Extended use of disposable pressure transducers. A bacteriologic evaluation. JAMA 1986;255:916-20.
16. Rickard C, Wallis SC, Courtney M, et al. Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use. An in vitro study. J Adv Nurs 2002;37:330-7.
17. Simon A, Fleischhack G, Wiszniewsky G, et al. Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resources. Infection 2006;34:258-63.
18. Rickard CM, Vannapraseuth B, McGrail MR, et al. A cross-sectional study investigating the relationship between intravenous infusate colonisation and fluid container hang time. J Clin Nurs 2009;18:3022-8.
19. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):s22-30.
20. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S12-21.
21. National Health and Medical Research Council in partnership with the Australian Commission on Safety and Quality in Healthcare. Australian guidelines for the prevention and control of infection in healthcare. Canberra: Department of Health and Aging, 2010.
22. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162-93.
23. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno AL, Waldvogel FA. eds. Infections associated with indwelling medical devices. Washington, DC: ASM Press, 1994:155-205.
24. Ducharme FM, Gauthier M, Lacroix J, et al. Incidence of infection related to arterial catheterization in children: a prospective study. Crit Care Med 1988;16:272-6.
25. O'Malley MK, Rhame FS, Cerra FB, et al. Value of routine pressure monitoring system changes after 72 hours of continuous use. Crit Care Med 1994;22:1424-30.
26. Darouiche RO, Raad I. Prevention of infections associated with vascular catheters. In: Vincent J-L. ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag, 1998:327-38.
27. de Moissac D, Jensen L. Changing IV administration sets: is 48 versus 24 hours safe for neutropenic patients with cancer. Oncol Nurs Forum 1998;25:907-13.
28. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000;19:1-8.
29. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
30. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296:1305-9.
31. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51 (RR-10):1-29.
32. Fortun J. Infections related to intravascular devices used for infusion therapy. Enferm Infecc Microbiol Clin 2008;26:168-74.
33. Macias AE, de Leon SP, Huertas M, et al. Endemic infusate contamination and related bacteremia. Am J Infect Control 2008;36:48-53.
34. Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ 2008;337:a339.
35. Cercenado E, Ena J, Rodriguez-Creixems M, et al. A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med 1990;150:1417-20.
36. Cornely OA, Bethe U, Pauls R, et al. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002;23:249-53.
37. Oncu S, Ozsut H, Yildirim A, et al. Central venous catheter related infections: risk factors and the effect of glycopeptide antibiotics. Ann Clin Microbiol Antimicrob 2003;2:3.
38. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983;118:839-51.